Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBioNTech SE Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$2.66 | -$2.03 | -$2.21 |
| Q2 2026 | 3 | -$2.78 | $0.30 | -$2.10 |
| Q3 2026 | 2 | -$3.58 | $3.73 | $0.97 |
| Q4 2026 | 1 | -$2.03 | -$0.68 | -$1.32 |
| Q1 2027 | 1 | -$2.93 | -$0.98 | -$1.90 |
| Q2 2027 | 1 | -$3.11 | -$1.04 | -$2.02 |
| Q3 2027 | 1 | -$0.36 | -$0.12 | -$0.24 |
| Q4 2027 | 1 | $0.42 | $1.27 | $0.82 |
BioNTech SE Earnings Date And Information
BioNTech SE last posted its earnings results on Tuesday, May 5th, 2026. The company reported $-2.28 earnings per share for the quarter, topping analysts' consensus estimates of $-2.52 by $0.24. The company had revenue of 120.04 M for the quarter and had revenue of 2.76 B for the year. BioNTech SE has generated $-5 earnings per share over the last year ($-4.51 diluted earnings per share) and currently has a price-to-earnings ratio of -15.93. BioNTech SE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
BioNTech SE Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | -$2.52 | -$2.14 | 0.38 | $180.21 M | $120.04 M |
| 03/10/2026 | Q4 2025 | -$0.22 | -$1.23 | -1.01 | $767.97 M | $898.89 M |
| 11/03/2025 | Q3 2025 | -$1.12 | -$0.12 | 1 | $720.33 M | $1.52 B |
| 08/04/2025 | Q2 2025 | -$2.69 | -$1.60 | 1.09 | $151.02 M | $260.80 M |
| 03/31/2025 | Q1 2025 | N/A | -$1.73 | N/A | $198.75 M | $182.80 M |
| 12/31/2024 | Q4 2024 | N/A | $1.08 | N/A | $1.14 B | $1.19 B |
| 09/28/2024 | Q3 2024 | N/A | $0.83 | N/A | $521.95 M | $1.24 B |
| 06/28/2024 | Q2 2024 | N/A | -$3.42 | N/A | $135.45 M | $128.70 M |
| 03/30/2024 | Q1 2024 | N/A | -$1.31 | N/A | $446.14 M | $187.60 M |
| 12/30/2023 | Q4 2023 | N/A | $1.88 | N/A | N/A | $1.48 B |
| 09/29/2023 | Q3 2023 | N/A | $0.69 | N/A | N/A | $895.30 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.79 | N/A | N/A | $167.70 M |
| 03/31/2023 | Q1 2023 | N/A | $2.05 | N/A | N/A | $1.28 B |
| 12/31/2022 | Q4 2022 | N/A | $8.94 | N/A | N/A | $4.28 B |
| 09/30/2022 | Q3 2022 | N/A | $6.98 | N/A | N/A | $3.46 B |
| 06/30/2022 | Q2 2022 | N/A | $6.45 | N/A | N/A | $3.20 B |
| 03/31/2022 | Q1 2022 | N/A | $14.24 | N/A | N/A | $6.37 B |
| 12/31/2021 | Q4 2021 | N/A | $12.95 | N/A | N/A | $5.53 B |
| 09/30/2021 | Q3 2021 | N/A | $13.14 | N/A | N/A | $6.09 B |
| 06/30/2021 | Q2 2021 | N/A | $11.42 | N/A | N/A | $5.31 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BioNTech SE Earnings: FAQ's
In the previous quarter, BioNTech SE (:BNTX) reported $-2.28 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.52 by $0.24.
The conference call for BioNTech SE's latest earnings report can be listened to online.
The conference call transcript for BioNTech SE's latest earnings report can be read online.
BioNTech SE (:BNTX) has a recorded annual revenue of $2.76 B.
BioNTech SE (:BNTX) has a recorded net income of $-1,091,261,192.BioNTech SE has generated $-4.51 earnings per share over the last four quarters.
BioNTech SE (:BNTX) has a price-to-earnings ratio of -15.93 and price/earnings-to-growth ratio is 0.16.